Tazarotene

Category
topical
Half-Life (t½)
TD: 18h
Formula
C21H21NO2S
Molecular Weight
351.46 g/mol
PubChem CID
5381
Aliases
Tazorac, Avage, Arazlo, AGN-190168

Pharmacological Mechanism

Acetylenic retinoid prodrug — rapidly hydrolysed by esterases in the skin to the active carboxylic-acid metabolite tazarotenic acid, which selectively activates RAR-β and RAR-γ. Potent normalisation of keratinocyte differentiation with anti-proliferative activity (basis for the psoriasis indication — reduces T-cell-driven keratinocyte hyperproliferation). Among topical retinoids, tazarotene is the most irritating, which is also why the newer 0.045% lotion vehicle exists. Systemic exposure to tazarotenic acid is <1% of applied dose but still drives a pregnancy-category X labelling.

Half-Life & Elimination Curve (TD: 18h)

100%50%25%12.5%0%0h0×t½18h1×t½36h2×t½54h3×t½3d4×t½3.8d5×t½0×t½ (0h): 100% remaining1×t½ (18h): 50% remaining2×t½ (36h): 25% remaining3×t½ (54h): 12.5% remaining4×t½ (3d): 6.3% remaining5×t½ (3.8d): 3.1% remaining
Elimination (TD)
  • 0×t½0h100%
  • 1×t½18h50%
  • 2×t½36h25%
  • 3×t½54h12.5%
  • 4×t½3d6.3%
  • 5×t½3.8d3.1%
Elimination t½18h (TD)
Rate Constant (ke)0.0385 h⁻¹
97% Washout (5×t½)3.8d

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References